 |
 |
|
Gregory H. Reaman, MD
Chair, Children’s Oncology Group
|
Gregory H. Reaman, MD, is the first group chair of the
Children’s Oncology Group (COG). The COG was formed in March 2000 by the merger
of 4 legacy pediatric cancer research organizations and is comprised of over
230 member institutions, responsible for the treatment of 90% of children with
cancer in North America.
Dr Reaman is a professor of pediatrics at The George Washington
University School of Medicine and Health Sciences and a member of the division
of Hematology-Oncology at the Children’s National Medical Center in Washington,
DC, which he directed for 17 years. Dr Reaman is a graduate of Loyola
University Chicago-Stritch School of Medicine, and completed his pediatrics
training at McGill University/The Montreal Children’s Hospital. His
postgraduate training in oncology was obtained at the Pediatric Oncology Branch
of the National Cancer Institute, where he served as an investigator prior to
coming to Children’s Hospital, and where he continues as a consultant.
Dr Reaman serves or has served on the Editorial Boards of
Leukemia, Journal of Clinical Oncology, Journal of Pediatric
Hematology/Oncology, Pediatric Blood and Cancer, The Oncologist, Cancer, and
Physicians Data Query, National Cancer Institute, as well as www.PLWC.org
(People Living with Cancer). He has served as an associate editor of Cancer and
currently serves as associate editor of Leukemia and Lymphoma. He holds the
position as the executive vice president for Medical and Scientific Affairs for
the National Childhood Cancer Foundation and is a member of its Board of
Trustees. Previously, he served on the Board of Directors of the American
Cancer Society and chaired its Task Force on Children and Cancer.
In addition, Dr Reaman serves on the Board of Directors of the
American Society of Clinical Oncology’s (ASCO) Patient Education Committee and
the Educational Program Committee, and is the Chair of the ASCO Membership
Committee. He is a member of the Alliance for Childhood Cancer, a member of the
Data Safety Monitoring Board of the National Cancer Institute’s Clinical
Oncology Program, and was a member of the Food and Drug Administration’s
Oncologic Drugs Advisory Committee; he currently chairs its Pediatric
Subcommittee. Dr Reaman is the author of more than 200 peer-reviewed
manuscripts.
|
|
|